$SAGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sage Therapeutics, Inc.. Get notifications about new insider transactions in Sage Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,509 | 154.8 K to 154.5 K (-0.16 %) |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,759 | 155 K to 154.8 K (-0.16 %) |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 155,009 | 155.3 K to 155 K (-0.16 %) |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 155,259 | 155.5 K to 155.3 K (-0.16 %) |
Nov 28 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | M | 8.92 | 10,000 | 89,200 | 167,038 | |
Nov 28 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 55.00 | 10,000 | 550,000 | 0 | 10 K to 0 (-100.00 %) |
Nov 28 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Buy | M | 8.92 | 10,000 | 89,200 | 10,000 | 0 to 10 K |
Nov 18 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 51.77 | 4,000 | 207,080 | 75,739 | 79.7 K to 75.7 K (-5.02 %) |
Nov 14 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 50.59 | 1,500 | 75,885 | 79,739 | 81.2 K to 79.7 K (-1.85 %) |
Nov 01 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 15,287 | 20,790 | 6,935 | |
Nov 01 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 15,287 | 20,790 | 155,509 | 140.2 K to 155.5 K (+10.90 %) |
Sep 09 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 40.93 | 2,500 | 102,325 | 81,239 | 83.7 K to 81.2 K (-2.99 %) |
Aug 19 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
Aug 19 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
Jul 19 2016 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 42.22 | 20,883 | 881,680 | 20,883 | ||
Jul 14 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 40.00 | 22,000 | 880,000 | 140,222 | 162.2 K to 140.2 K (-13.56 %) |
Jul 14 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 49.55 | 5,000 | 247,750 | 83,739 | 88.7 K to 83.7 K (-5.63 %) |
Jun 24 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 24 2016 | SAGE | Sage Therapeutics, ... | PIEN HOWARD H | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 24 2016 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 24 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 24 2016 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
May 18 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
May 18 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 423 | 0 | 678,569 | 679 K to 678.6 K (-0.06 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 847 | 0 | 678,992 | 679.8 K to 679 K (-0.12 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 847 | 0 | 679,839 | 680.7 K to 679.8 K (-0.12 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 423 | 0 | 680,686 | 681.1 K to 680.7 K (-0.06 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 847 | 0 | 681,109 | 682 K to 681.1 K (-0.12 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 847 | 0 | 681,956 | 682.8 K to 682 K (-0.12 %) | |
Apr 05 2016 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 847 | 0 | 682,803 | 683.7 K to 682.8 K (-0.12 %) | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | A | 28.63 | 60,000 | 1,717,800 | 60,000 | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 28.63 | 25,000 | 715,750 | 25,000 | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 28.63 | 20,000 | 572,600 | 20,000 | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Option Exercise | A | 28.63 | 15,000 | 429,450 | 15,000 | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | General Counsel | Option Exercise | A | 28.63 | 40,000 | 1,145,200 | 40,000 | |
Feb 10 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | A | 28.63 | 22,500 | 644,175 | 22,500 | |
Apr 21 2016 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 21,000 | 9,450 | 112,100 | |
Apr 21 2016 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 21,000 | 9,450 | 46,948 | 25.9 K to 46.9 K (+80.93 %) |
Apr 21 2016 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 38.00 | 21,000 | 798,000 | 25,948 | 46.9 K to 25.9 K (-44.73 %) |
Jan 26 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 40.02 | 20,000 | 800,400 | 162,222 | 182.2 K to 162.2 K (-10.98 %) |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Option Exercise | M | 0.45 | 4,000 | 1,800 | 61,495 | |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Buy | M | 0.45 | 4,000 | 1,800 | 88,739 | 84.7 K to 88.7 K (+4.72 %) |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Buy | P | 49.56 | 176 | 8,723 | 84,739 | 84.6 K to 84.7 K (+0.21 %) |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 20,000 | 9,000 | 400,360 | |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 20,000 | 9,000 | 101,226 | 81.2 K to 101.2 K (+24.62 %) |
Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | P | 49.56 | 226 | 11,201 | 81,226 | 81 K to 81.2 K (+0.28 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,226 | 49.2 K to 65.2 K (+32.47 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
Nov 12 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 25,411 | 0 | 107,950 | 82.5 K to 108 K (+30.79 %) |
Nov 12 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 500,000 | 0 | 1,124,699 | 1.6 M to 1.1 M (-30.77 %) |
Sep 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 21,000 | 9,450 | 133,100 | |
Sep 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 46.42 | 6,000 | 278,520 | 46,948 | 52.9 K to 46.9 K (-11.33 %) |
Sep 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 21,000 | 9,450 | 52,948 | 31.9 K to 52.9 K (+65.73 %) |
Sep 29 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 25,412 | 0 | 85,539 | 60.1 K to 85.5 K (+42.26 %) |
Sep 29 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 500,000 | 0 | 1,624,699 | 2.1 M to 1.6 M (-23.53 %) |
Sep 18 2015 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | General Counsel | Option Exercise | A | 56.27 | 110,000 | 6,189,700 | 110,000 | |
Sep 09 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 54.84 | 3,000 | 164,520 | 84,563 | 87.6 K to 84.6 K (-3.43 %) |
Sep 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 52.10 | 9,518 | 495,888 | 683,650 | 693.2 K to 683.7 K (-1.37 %) | |
Sep 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 52.69 | 10,482 | 552,297 | 693,168 | 703.7 K to 693.2 K (-1.49 %) | |
Sep 01 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 53.12 | 12,000 | 637,440 | 31,948 | 43.9 K to 31.9 K (-27.30 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,240 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 65.34 | 1,300 | 84,942 | 0 | 1.3 K to 0 (-100.00 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 67.14 | 1,220 | 81,911 | 1,300 | 2.5 K to 1.3 K (-48.41 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 67.66 | 3,480 | 235,457 | 2,520 | 6 K to 2.5 K (-58.00 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 65.88 | 338 | 22,267 | 87,563 | 87.9 K to 87.6 K (-0.38 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 67.20 | 900 | 60,480 | 87,901 | 88.8 K to 87.9 K (-1.01 %) |
Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 67.95 | 2,762 | 187,678 | 88,801 | 91.6 K to 88.8 K (-3.02 %) |
Aug 04 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 67.06 | 12,000 | 804,720 | 182,222 | 194.2 K to 182.2 K (-6.18 %) |
Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 66.42 | 6,020 | 399,848 | 703,650 | 709.7 K to 703.7 K (-0.85 %) | |
Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 67.05 | 9,158 | 614,044 | 709,670 | 718.8 K to 709.7 K (-1.27 %) | |
Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 67.98 | 4,822 | 327,800 | 718,828 | 723.7 K to 718.8 K (-0.67 %) | |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 1,936 | 871 | 154,100 | |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 68.67 | 654 | 44,910 | 43,948 | 44.6 K to 43.9 K (-1.47 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 69.60 | 900 | 62,640 | 44,602 | 45.5 K to 44.6 K (-1.98 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 70.91 | 400 | 28,364 | 45,502 | 45.9 K to 45.5 K (-0.87 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 72.08 | 826 | 59,538 | 45,902 | 46.7 K to 45.9 K (-1.77 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 73.64 | 220 | 16,201 | 46,728 | 46.9 K to 46.7 K (-0.47 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 68.50 | 636 | 43,566 | 46,948 | 47.6 K to 46.9 K (-1.34 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 69.38 | 800 | 55,504 | 47,584 | 48.4 K to 47.6 K (-1.65 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 72.00 | 500 | 36,000 | 48,384 | 48.9 K to 48.4 K (-1.02 %) |
Jul 29 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 1,936 | 871 | 48,884 | 46.9 K to 48.9 K (+4.12 %) |
Jul 24 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.79 | 3,000 | 230,370 | 81,000 | 84 K to 81 K (-3.57 %) |
Jul 06 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 68.00 | 4,000 | 272,000 | 91,563 | 95.6 K to 91.6 K (-4.19 %) |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 67.46 | 803 | 54,170 | 723,650 | 724.5 K to 723.7 K (-0.11 %) | |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 68.12 | 9,702 | 660,900 | 724,453 | 734.2 K to 724.5 K (-1.32 %) | |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 68.90 | 1,859 | 128,085 | 734,155 | 736 K to 734.2 K (-0.25 %) | |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 70.50 | 1,600 | 112,800 | 736,014 | 737.6 K to 736 K (-0.22 %) | |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 71.47 | 5,336 | 381,364 | 737,614 | 743 K to 737.6 K (-0.72 %) | |
Jul 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 72.44 | 700 | 50,708 | 742,950 | 743.7 K to 743 K (-0.09 %) | |
Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 70.62 | 1,757 | 124,079 | 194,222 | 196 K to 194.2 K (-0.90 %) |
Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.43 | 4,905 | 350,364 | 195,979 | 200.9 K to 196 K (-2.44 %) |
Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 72.79 | 9,338 | 679,713 | 200,884 | 210.2 K to 200.9 K (-4.44 %) |
Jun 25 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 6,000 | 2,700 | 40,300 | |
Jun 25 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 74.06 | 6,000 | 444,360 | 46,948 | 52.9 K to 46.9 K (-11.33 %) |
Jun 25 2015 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 6,000 | 2,700 | 52,948 | 46.9 K to 52.9 K (+12.78 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 53,992 | 0 | 60,127 | 6.1 K to 60.1 K (+880.07 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 1,062,345 | 0 | 2,124,699 | 3.2 M to 2.1 M (-33.33 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,062,345 | 0 | 2,124,699 | 3.2 M to 2.1 M (-33.33 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,402 | 0 | 27,330 | 17.9 K to 27.3 K (+52.44 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 147,971 | 66,587 | 0 | |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 128,629 | 57,883 | 0 | |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 45,255 | 20,365 | 84,000 | 38.7 K to 84 K (+116.80 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 32,745 | 14,735 | 38,745 | 6 K to 38.7 K (+545.75 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 75.51 | 29,303 | 2,212,766 | 6,000 | 35.3 K to 6 K (-83.00 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.09 | 64,973 | 4,943,705 | 35,303 | 100.3 K to 35.3 K (-64.79 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.85 | 14,146 | 1,087,096 | 100,276 | 114.4 K to 100.3 K (-12.36 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.13 | 6,804 | 531,570 | 114,422 | 121.2 K to 114.4 K (-5.61 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 115,226 | 51,852 | 121,226 | 6 K to 121.2 K (+1,920.43 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.22 | 11,329 | 886,173 | 6,000 | 17.3 K to 6 K (-65.38 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.88 | 62,364 | 4,919,116 | 17,329 | 79.7 K to 17.3 K (-78.26 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 79.97 | 5,707 | 456,387 | 79,693 | 85.4 K to 79.7 K (-6.68 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 81.51 | 2,420 | 197,246 | 85,400 | 87.8 K to 85.4 K (-2.76 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 83.89 | 1,554 | 130,361 | 87,820 | 89.4 K to 87.8 K (-1.74 %) |
Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 83,374 | 37,518 | 89,374 | 6 K to 89.4 K (+1,389.57 %) |
Jun 08 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | M | 8.92 | 5,500 | 49,060 | 132,169 | |
Jun 08 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 78.56 | 1,200 | 94,272 | 6,000 | 7.2 K to 6 K (-16.67 %) |
Jun 08 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 79.95 | 4,300 | 343,785 | 7,200 | 11.5 K to 7.2 K (-37.39 %) |
Jun 08 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Buy | M | 8.92 | 5,500 | 49,060 | 11,500 | 6 K to 11.5 K (+91.67 %) |
Jun 08 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | See Remarks | Sell | S | 80.10 | 2,500 | 200,250 | 95,563 | 98.1 K to 95.6 K (-2.55 %) |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 71.36 | 8,705 | 621,153 | 743,650 | 752.4 K to 743.7 K (-1.16 %) | |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 72.06 | 3,291 | 237,162 | 752,355 | 755.6 K to 752.4 K (-0.44 %) | |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 73.13 | 4,604 | 336,710 | 755,646 | 760.3 K to 755.6 K (-0.61 %) | |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 74.05 | 3,400 | 251,774 | 760,250 | 763.7 K to 760.3 K (-0.45 %) | |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.21 | 200 | 14,241 | 210,222 | 210.4 K to 210.2 K (-0.10 %) |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.67 | 5,231 | 374,909 | 210,422 | 215.7 K to 210.4 K (-2.43 %) |
Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 72.93 | 5,624 | 410,181 | 215,653 | 221.3 K to 215.7 K (-2.54 %) |